Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1287795-35-0

Post Buying Request

1287795-35-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1287795-35-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1287795-35-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,7,7,9 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1287795-35:
(9*1)+(8*2)+(7*8)+(6*7)+(5*7)+(4*9)+(3*5)+(2*3)+(1*5)=220
220 % 10 = 0
So 1287795-35-0 is a valid CAS Registry Number.

1287795-35-0Relevant articles and documents

Antimicrobial agents

-

Page/Page column 30, (2017/12/27)

The invention provides methods of treating a bacterial infection in a mammal comprising administering to the mammal a substituted bicyclic heteroaromatic ring compound of formula I: wherein two of X1 to X8 are N and the remaining of X1 to X8 are CH; or a pharmaceutically acceptable salt thereof, as well as novel compounds of formula I and salts thereof and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof.

One-pot synthesis of 2-substituted quinoxalines using K10-montmorillonite as heterogeneous catalyst

Jeganathan, Mariappan,Dhakshinamoorthy, Amarajothi,Pitchumani, Kasi

supporting information, p. 1616 - 1620 (2014/03/21)

An efficient one-pot synthesis of 2-substituted quinoxalines from 1,2-diamines and phenacyl bromides is developed using K10-montmorillonite (K10 clay) as a catalyst at 50 C in acetonitrile medium. This method offers an easy route for the synthesis of subs

ANTIMICROBIAL AGENTS

-

Page/Page column 26, (2013/07/25)

The invention provides methods of treating a bacterial infection in a mammal comprising administering to the mammal a substituted bicyclic heteroaromatic ring compound of formula I: wherein two of X1 to X8 are N and the remaining of X1 to X8 are CH; or a pharmaceutically acceptable salt thereof, as well as novel compounds of formula I and salts thereof and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1287795-35-0